{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:27:22Z","timestamp":1775734042139,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":6087,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Variceal hemorrhage continues to be a major cause of morbidity and mortality in cirrhotic patients. Transjugular intrahepatic portosystemic shunt (TIPS) is gaining wide acceptance as a treatment for several complications of portal hypertension. The aim of the current randomized study was to compare the transjugular shunt and endoscopic sclerotherapy (ES) for the prevention of variceal rebleeding (VB) in cirrhotic patients. Forty\u2013six consecutive cirrhotic patients with variceal bleeding were randomly allocated to receive either transjugular shunt (22 patients) or ES (24 patients) 24 hours after control of bleeding. VB (50% vs. 9%) and early (first 6 weeks) VB (33% vs. 5%) were significantly more frequent in sclerotherapy patients; the actuarial probability of being free of VB was higher in the shunt group (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .002). Eight patients (33%) of the sclerotherapy group and 3 patients (15%) of the shunt group died; the actuarial probability of survival was higher for the shunted patients (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05); 6 patients in the sclerotherapy group and none in the shunt group died from VB (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .05). No difference was found in the proportion of patients with clinically evident hepatic encephalopathy (HE). These results show that the transjugular shunt is more effective than sclerotherapy in the prevention of both early and long\u2013term VB. Moreover, a significant improvement in survival was found in the shunt group.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.510290125","type":"journal-article","created":{"date-parts":[[2004,7,27]],"date-time":"2004-07-27T23:36:12Z","timestamp":1090971372000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":121,"title":["Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Sclerotherapy for the Prevention of Variceal Rebleeding After Recent Variceal Hemorrhage"],"prefix":"10.1097","volume":"29","author":[{"given":"Luis","family":"Garc\u00eda-Villarreal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mart\u00ednez-Lagares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemencia","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Marrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Monescillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Hern\u00e1ndez-Cabrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1002\/hep.510290125-BIB1|cit1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/0016-5085(81)90144-X","article-title":"The course of patients after variceal hemorrhage","volume":"80","author":"Graham","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510290125-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2165\/00003495-198900372-00004","article-title":"Morbidity and mortality of portal hypertension","volume":"37","author":"Ready","year":"1989","journal-title":"Drugs"},{"key":"10.1002\/hep.510290125-BIB3|cit3","first-page":"71","article-title":"Therapeutic controversies and randomized controlled trials (RCTs): prevention of bleeding and rebleeding in cirrhosis","volume":"2","author":"Pagliaro","year":"1989","journal-title":"Gastroenterol Int"},{"key":"10.1002\/hep.510290125-BIB4|cit4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.1840220145","article-title":"The treatment of portal hypertension: a meta-analytic review","volume":"22","author":"D'Amico","year":"1995","journal-title":"Hepatology"},{"key":"10.1002\/hep.510290125-BIB5|cit5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02575474","article-title":"The transjugular intrahepatic portosystemic stent-shunt: results of a pilot study","volume":"13","author":"Richter","year":"1990","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1002\/hep.510290125-BIB6|cit6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1148\/radiology.187.2.8475283","article-title":"Creation of transjugular intrahepatic portosystemic shunt with the wallstent endoprosthesis: results in 100 patients","volume":"187","author":"La Berge","year":"1993","journal-title":"Radiology"},{"key":"10.1002\/hep.510290125-BIB7|cit7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.1997.v112.pm9041251","article-title":"The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts","volume":"112","author":"Sanyal","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510290125-BIB8|cit8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1053\/gast.1996.v110.pm8608893","article-title":"Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage","volume":"110","author":"Cabrera","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510290125-BIB9|cit9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-126-11-199706010-00001","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized controlled trial","volume":"126","author":"Sanyal","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1002\/hep.510290125-BIB10|cit10","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-126-11-199706010-00002","article-title":"Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized controlled trial","volume":"126","author":"Cello","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1002\/hep.510290125-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(96)08189-5","article-title":"Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding","volume":"349","author":"R\u00f6ssle","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/hep.510290125-BIB12|cit12","first-page":"1115","article-title":"A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices","volume":"26","author":"Jalan","year":"1997","journal-title":"Hepatology"},{"key":"10.1002\/hep.510290125-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1053\/gast.1997.v113.pm9352865","article-title":"Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding","volume":"113","author":"Sauer","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510290125-BIB14|cit14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/hep.510270109","article-title":"Transjugular intrahepatic portosystemic shunt versus sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial","volume":"27","author":"Merli","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/hep.510290125-BIB15|cit15","first-page":"A1374","article-title":"Transjugular intrahepatic portosystemic stent shunt (TIPS) vs endoscopic banding in the prevention of variceal rebleeding: interim analysis of a randomized study [Abstract]","volume":"112","author":"Sauer","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1002\/hep.510290125-BIB16|cit16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(57)90005-3","article-title":"The electroencephalography in liver disease","volume":"2","author":"Parsons-Smith","year":"1957","journal-title":"Lancet"},{"key":"10.1002\/hep.510290125-BIB17|cit17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0168-8278(92)90044-P","article-title":"Definitions, methodology and therapeutic strategies in portal hypertension","volume":"15","author":"de Franchis","year":"1992","journal-title":"J Hepatol"},{"key":"10.1002\/hep.510290125-BIB18|cit18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","article-title":"Portal pressure, presence of gastro-oesophageal varices and variceal bleeding","volume":"5","author":"Garc\u00eda-Tsao","year":"1985","journal-title":"Hepatology"},{"key":"10.1002\/hep.510290125-BIB19|cit19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/hep.1840090602","article-title":"Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates","volume":"9","author":"Burroughs","year":"1989","journal-title":"Hepatology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.510290125","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-199901000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T11:27:59Z","timestamp":1733052479000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-199901000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.510290125","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}